Status:
COMPLETED
Relationship Between Polymorphism of Heat Shock Protein 70 Gene and Hepatocellular Carcinoma
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
Phase:
NA
Brief Summary
Polymorphisms of HSP70 and tumor necrosis factor-alpha promoter in patients with hepatocellular carcinoma, chronic liver disease and healthy controls will be measured by PCR-RFLP or direct sequencing....
Detailed Description
Heat shock protein 70 (HSP 70) may be involved in various aspects of immune system including infection, autoimmunity, and tumor immunity. The relationship between HSP70 expression, disease activity an...
Eligibility Criteria
Inclusion
- History proven HCC patients
Exclusion
- No-definite diagnosed patients
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00769535
Start Date
January 1 2006
End Date
June 1 2008
Last Update
April 30 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Medical University
Kaohsiung City, Kaohsiung, Taiwan, 807
2
Kaohsiung Medical University
Kaohsiung City, Kaohsiun, Taiwan, 807